Urologix develops, manufactures and markets minimally-invasive medical products for the treatment of urological disorders. The company has developed non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH). Its less-invasive technology has been used on more than 225,000 patients, establishing Urologix as a clear leader in BPH treatment.
TheraSense was a medical device company in Alameda, California developing two new product lines to dramatically change the way people with diabetes test and monitor their glucose levels. TheraSense was acquired by Abbott Laboratories in April 2004.
Spinal Dynamics was a medical device company that developed one of the leading artificial disk implants, Aeto, to replace natural intervertebral disks damaged by degenerative joint disease. The company was acquired by Medtronic in 2002.
PercuSurge pioneered a new market segment in interventional cardiology products with a series of balloon catheters designed to trap and remove the potentially harmful debris that breaks loose during balloon angioplasty and stent placement procedures. The company was acquired by Medtronic in 2000.
Nanogen's advanced technologies provided researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately, help treat disease. The company's products included real-time PCR reagents, the NanoChip(R) 400 electronic microarray platform and a line of rapid, point-of-care diagnostic tests. Nanogen was acquired by Epoch Biosciences in 2009.
LenSx Lasers developed a next-generation femtosecond laser that operates inside the eye to make cataract surgery safer and more effective. The founding team is the same team from IntraLase, a highly successful InterWest company that manufactured lasers for vision correction.
IntraLase developed a revolutionary all-laser surgical technology that made precise surgical flaps for laser vision correction procedures that has seen enormous success in the field of refractive surgery. IntraLase had an initial public offering in 2004 and was acquired by Advanced Medical Optics in 2007. Advanced Medial Optics was acquired by Abbott Labs in 2009.
IVT was founded in 1983 to develop new technologies and devices for use in the field of intravascular intervention in arteriosclerotic disease. The company introduced tools for use in vascular microsurgery as well as in traditional balloon dilatation intervention. The company was acquired by Boston Scientific in 2001.
Innovasive Devices made and sold sports medicine devices used in the surgical repair of soft tissue in the knees and shoulders. It was acquired by Johnson & Johnson in 1999.
Epicor Medical was founded in 1999 to develop new devices and procedures for the treatment of atrial fibrillation using high-intensity focused ultrasound. Epicor Medical's innovative approach to treating atrial fibrillation stands to cure patients, while minimizing complications associated with most invasive treatments available today. St. Jude Medical acquired the company in 2004.